4083674
AZD0780 - an oral PCSK9 inhibitor with a novel mode of action for the treatment of cardiovascular disease
Date
August 21, 2024
Related Products
Lunch and Learning: Looking Beyond the Ivory Tower: Developing a Business and Intellectual
Property Strategy for Academic Drug Discovery
DIVISION/COMMITTEE: [MEDI] Division of Medicinal Chemistry
Gemcitabine encapsulation in aluminum MOF: Delayed release and PANC-1 cytotoxicity
Pancreatic cancer remains one of the most challenging malignancies to treat, with limited therapeutic options and poor prognosis…
ACS MEDI Long Range Planning Committee meeting
DIVISION/COMMITTEE: [MEDI] Division of Medicinal Chemistry